Nephrocare Health Services Limited will attend an analyst and institutional investor conference on June 11, 2026. The virtual meeting, hosted by Choice Broking, will allow company officials to engage with the investment community based on publicly available information.

The conference is scheduled to commence at 11:00 A.M. IST. The company stated that no unpublished price sensitive information (UPSI) is intended to be discussed during the interactions. The disclosure was submitted to the exchanges pursuant to Regulation 30 read with Schedule III of the SEBI Listing Regulations.

The schedule for the meeting is detailed below:

Nephrocare Health Services Limited noted that changes to the schedule may occur due to exigencies on the part of the host or the company. The disclosure was signed by Kishore Kathri, Company Secretary & Compliance Officer, and is available on the company's official website.

Nephrocare Health Services Limited will attend an investor conference hosted by Bank of America on June 04, 2026, in Hyderabad. The meeting is part of the BoFA Healthcare Tour and will include both group and one-on-one sessions with institutional investors. The company confirmed that discussions will be based solely on publicly available information and no unpublished price sensitive information (UPSI) will be disclosed.

The disclosure was made pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015. Kishore Kathri, the Company Secretary & Compliance Officer, signed the intimation on May 27, 2026.

The schedule for the meeting is detailed below:

Nephrocare Health Services Limited noted that changes to the schedule may occur due to exigencies on the part of the host or the company. The information is available on the company’s official website.